Home/Filings/4/0001209191-17-008914
4//SEC Filing

NEUROCRINE BIOSCIENCES INC 4

Accession 0001209191-17-008914

$NBIXCIK 0000914475operating

Filed

Feb 7, 7:00 PM ET

Accepted

Feb 8, 7:42 PM ET

Size

5.5 KB

Accession

0001209191-17-008914

Insider Transaction Report

Form 4
Period: 2017-02-06
Gros David-Alexandre C
President & COO
Transactions
  • Award

    Restricted Stock Option

    2017-02-06+25,00025,000 total
    Common Stock (25,000 underlying)
Footnotes (2)
  • [F1]Each Restricted Stock Unit represents a contingent right to receive one share of the Neurocrine Common Stock.
  • [F2]The Restricted Stock Units will vest annually at 1/4 of the units vesting on each of February 6, 2018, February 6, 2019, February 6, 2020, and February 6, 2021.

Issuer

NEUROCRINE BIOSCIENCES INC

CIK 0000914475

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000914475

Filing Metadata

Form type
4
Filed
Feb 7, 7:00 PM ET
Accepted
Feb 8, 7:42 PM ET
Size
5.5 KB